Celldex Cancer Vaccine May Get Fast

Barron'sCelldex Cancer Vaccine May Get Fast-TrackedBarron'sWe remain impressed and reiterate our prediction that Rintega will be the second cancer vaccine approved in the U.S.. Recall this study has enrolled 374 patients and is a randomized, double-blind, placebo-controlled study comparing Rintega plus [Merck ...and more »

Share this post